These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20156712)

  • 21. Platelet reactivity and stent thrombosis: still some issues to solve.
    Perez de Prado A; Cuellas C; Diego A; de Miguel A; Fernandez-Vazquez F
    J Am Coll Cardiol; 2009 Aug; 54(7):666-7; author reply 667-8. PubMed ID: 19660707
    [No Abstract]   [Full Text] [Related]  

  • 22. Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
    Jang SW; Kim DB; Kwon BJ; Shin D; Her SH; Park CS; Park HJ; Park MW; Cho EJ; Rho TH; Kim JH
    Int J Cardiol; 2010 Apr; 140(1):e8-11. PubMed ID: 19117624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
    Jeong YH; Park Y; Kim IS; Yun SE; Kang MK; Hwang SJ; Kwak CH; Hwang JY
    Thromb Haemost; 2010 Dec; 104(6):1286-9. PubMed ID: 20838742
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
    Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Gurbel PA; Xu K; Parise H; Kirtane AJ; Brodie BR; Mehran R; Stuckey TD;
    Lancet; 2013 Aug; 382(9892):614-23. PubMed ID: 23890998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
    Lee SW; Chun KJ; Park SW; Kim HS; Kim YH; Yun SC; Kim WJ; Lee JY; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Jon S; Cho YH; Lee NH; Kim JH; Park SJ
    Am J Cardiol; 2010 Jan; 105(2):168-73. PubMed ID: 20102913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
    López Mínguez JR; Nogales Asensio JM; Doncel Vecino LJ; Sandoval J; Romany S; Martínez Romero P; Fernández Díaz JA; Fernández Portales J; González Fernández R; Martínez Cáceres G; Merchán Herrera A; Alfonso Manterola F;
    EuroIntervention; 2014 May; 10(1):50-7. PubMed ID: 24832638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.
    Geisler T; Zürn C; Simonenko R; Rapin M; Kraibooj H; Kilias A; Bigalke B; Stellos K; Schwab M; May AE; Herdeg C; Gawaz M
    Eur Heart J; 2010 Jan; 31(1):59-66. PubMed ID: 19812059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
    Chen JL; Gao LJ; Yang YJ; Li JJ; Qiao SB; Xu B; Huang JH; Yao M; Qin XW; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Gao RL
    Chin Med J (Engl); 2010 Apr; 123(7):778-81. PubMed ID: 20497663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understand the power of Plavix. This antiplatelet drug prevents in-stent clots in women as well as men.
    Heart Advis; 2010 Apr; 13(4):C. PubMed ID: 23038821
    [No Abstract]   [Full Text] [Related]  

  • 32. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials).
    Lee SW; Lee JY; Ahn JM; Park DW; Han S; Park YK; Lee WS; Jang JY; Kwon CH; Park GM; Cho YR; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2013 Dec; 112(11):1738-44. PubMed ID: 24063835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cilostazol and clopidogrel after successful coronary stenting.
    Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ
    Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous left anterior descending and right coronary stent thrombosis after aspirin withdrawal.
    Omar HR; Mangar D; Karlnoski R; Abdelmalak HD; Camporesi EM
    Am J Emerg Med; 2012 Nov; 30(9):2093.e5-8. PubMed ID: 22386339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.
    Schulz S; Sibbing D; Braun S; Morath T; Mehilli J; Massberg S; Byrne RA; Schömig A; Kastrati A
    Am Heart J; 2010 Aug; 160(2):355-61. PubMed ID: 20691843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stent thrombosis: consider also low response to antiplatelets.
    Wiper AJ; Roberts DH
    BMJ; 2007 Jan; 334(7584):57. PubMed ID: 17218673
    [No Abstract]   [Full Text] [Related]  

  • 39. In-stent restenosis in a polytetrafluoroethylene covered stent combined with drug eluting stents: potential pathogenesis revealed by optical coherence tomography.
    Yang Q; Liu W; Fang F; Yu CM; Zhou YJ
    Int J Cardiol; 2015 Nov; 198():42-4. PubMed ID: 26151708
    [No Abstract]   [Full Text] [Related]  

  • 40. Bridging with GP IIb/IIIa inhibitors after abdominal surgery in a patient presenting with late stent thrombosis of a drug-eluting stent and who cannot receive oral antiplatelet treatment.
    Ben-Dor I; Waksman R
    J Invasive Cardiol; 2009 Apr; 21(4):E73-6. PubMed ID: 19342766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.